search
Back to results

Role Of Self-monitoring of Blood Glucose and Intensive Education in Patients With Type 2 Diabetes Not Receiving Insulin (ROSES)

Primary Purpose

Type 2 Diabetes

Status
Completed
Phase
Phase 3
Locations
Italy
Study Type
Interventional
Intervention
SMBG plus intensive education
Sponsored by
Consorzio Mario Negri Sud
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Type 2 Diabetes focused on measuring Diabetes, Self monitoring blood glucose

Eligibility Criteria

45 Years - 75 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Patients with Type 2 diabetes (known diabetes or new diagnosis) seen for the first time in the diabetes outpatient clinic;
  • Patients on treatment with OHA monotherapy (i.e. metformin alone or sulphonylureas alone or TZDs alone);
  • No need for insulin treatment;
  • Male and female patients, aged between 45-75 years;
  • Hba1c values between 7% and 9% included (considering a value of 6.0% as the upper limit of normal value)
  • No experience of self monitoring of blood glucose in the previous 12 months (SMBG performed with a frequency of < 1 times/week)
  • Ability and willingness to comply with all study requirements
  • Signature of consent form

Exclusion Criteria:

  • Patients incapable to perform SMBG
  • Patients needing insulin or multiple OHA association therapy
  • Patients needing a regular use of SMBG (e.g. frequent hypoglycemic episodes)
  • Diabetes care not exclusively managed by diabetic clinics
  • Patients with serious underlying medical or psychiatric condition

Sites / Locations

  • Consorzio Mario Negri Sud

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

No Intervention

Arm Label

SMBG + intensive education

Usual Care

Arm Description

Patients will receive specific educational interventions to teach them how to perform Self monitoring Blood Glucose (SMBG), how to modify diet and level of physical activity according to blood glucose levels, and the actions to be undertaken in case of abnormal values (hypoglycemia, particularly elevated glucose levels). Patients will be instructed to modify their lifestyle habits (diet, physical activity) in order to reach specific goals (weight reduction, reduction in fat consumption intake, reduction in saturated fat intake, increase in fiber intake, regular physical activity.

Usual Care

Outcomes

Primary Outcome Measures

Improvement of metabolic control
Aim of this study is to evaluate the efficacy of Self Monitoring Blood Glucose and Intensive Education in terms of improvement of metabolic control expressed as HbA1c levels after 6 months.

Secondary Outcome Measures

Reduction in prandial Blood Glucose excursions
Percentage of patients needing therapy modifications
Percentage of patients reaching target HbA1c (i.e. <7.0%)

Full Information

First Posted
August 4, 2010
Last Updated
August 5, 2010
Sponsor
Consorzio Mario Negri Sud
Collaborators
LifeScan
search

1. Study Identification

Unique Protocol Identification Number
NCT01176149
Brief Title
Role Of Self-monitoring of Blood Glucose and Intensive Education in Patients With Type 2 Diabetes Not Receiving Insulin
Acronym
ROSES
Official Title
Role Of Self-monitoring of Blood Glucose and Intensive Education in Patients With Type 2 Diabetes Not Receiving Insulin: a Pilot Study
Study Type
Interventional

2. Study Status

Record Verification Date
August 2010
Overall Recruitment Status
Completed
Study Start Date
March 2007 (undefined)
Primary Completion Date
April 2010 (Actual)
Study Completion Date
April 2010 (Actual)

3. Sponsor/Collaborators

Name of the Sponsor
Consorzio Mario Negri Sud
Collaborators
LifeScan

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
The aim of this pilot study is to evaluate the validity and feasibility of an educational approach involving nurses, combined with SMBG, aimed at lifestyle modification and timely changes in therapy, when needed.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Type 2 Diabetes
Keywords
Diabetes, Self monitoring blood glucose

7. Study Design

Primary Purpose
Treatment
Study Phase
Phase 3
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
62 (Actual)

8. Arms, Groups, and Interventions

Arm Title
SMBG + intensive education
Arm Type
Experimental
Arm Description
Patients will receive specific educational interventions to teach them how to perform Self monitoring Blood Glucose (SMBG), how to modify diet and level of physical activity according to blood glucose levels, and the actions to be undertaken in case of abnormal values (hypoglycemia, particularly elevated glucose levels). Patients will be instructed to modify their lifestyle habits (diet, physical activity) in order to reach specific goals (weight reduction, reduction in fat consumption intake, reduction in saturated fat intake, increase in fiber intake, regular physical activity.
Arm Title
Usual Care
Arm Type
No Intervention
Arm Description
Usual Care
Intervention Type
Behavioral
Intervention Name(s)
SMBG plus intensive education
Primary Outcome Measure Information:
Title
Improvement of metabolic control
Description
Aim of this study is to evaluate the efficacy of Self Monitoring Blood Glucose and Intensive Education in terms of improvement of metabolic control expressed as HbA1c levels after 6 months.
Secondary Outcome Measure Information:
Title
Reduction in prandial Blood Glucose excursions
Title
Percentage of patients needing therapy modifications
Title
Percentage of patients reaching target HbA1c (i.e. <7.0%)

10. Eligibility

Sex
All
Minimum Age & Unit of Time
45 Years
Maximum Age & Unit of Time
75 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Patients with Type 2 diabetes (known diabetes or new diagnosis) seen for the first time in the diabetes outpatient clinic; Patients on treatment with OHA monotherapy (i.e. metformin alone or sulphonylureas alone or TZDs alone); No need for insulin treatment; Male and female patients, aged between 45-75 years; Hba1c values between 7% and 9% included (considering a value of 6.0% as the upper limit of normal value) No experience of self monitoring of blood glucose in the previous 12 months (SMBG performed with a frequency of < 1 times/week) Ability and willingness to comply with all study requirements Signature of consent form Exclusion Criteria: Patients incapable to perform SMBG Patients needing insulin or multiple OHA association therapy Patients needing a regular use of SMBG (e.g. frequent hypoglycemic episodes) Diabetes care not exclusively managed by diabetic clinics Patients with serious underlying medical or psychiatric condition
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Antonio Nicolucci, MD
Organizational Affiliation
Consorzio Mario Negri Sud
Official's Role
Study Director
Facility Information:
Facility Name
Consorzio Mario Negri Sud
City
Santa Maria Imbaro
State/Province
Chieti
ZIP/Postal Code
66030
Country
Italy

12. IPD Sharing Statement

Learn more about this trial

Role Of Self-monitoring of Blood Glucose and Intensive Education in Patients With Type 2 Diabetes Not Receiving Insulin

We'll reach out to this number within 24 hrs